| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Intitute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, Georgia 30912
p73, a potential tumor suppressor, is a p53 homologue. Transient over expression of p73 in cells can induce apoptosis and p21, a cellular p53 target gene primarily responsible for p53-dependent cell cycle arrest. To further characterize the role of p73 in tumor suppression, we established several groups of cell lines that inducibly express p73 under a tetracycline-regulated promoter. By using these cell lines, we found that p73 can induce both cell cycle arrest and apoptosis. We also found that p73 can activate some but not all of the previously identified p53 cellular target genes. Furthermore, we found that the transcriptional activities of p53, p73
, and p73ß to induce their common cellular target genes differ among one another. These results suggest that p73 is both similar to and different from p53 in their signaling pathways leading to tumor suppression.
1 Supported in part by National Cancer Institute Grant CA 76069 and the United States Department of Defense Army Breast Cancer Program Grant DAMD17-97-I-7019.
2 These authors contributed equally to this work.
3 To whom requests for reprints should be addressed, at CB-2803/IMMAG, Medical College of Georgia, Augusta, GA 30912. Phone: (706) 721-8760; Fax: (706) 721-8752; E-mail: xchen@mail.mcg.edu.
Received 9/ 2/98. Accepted 10/ 1/98.
This article has been cited by other articles:
![]() |
S. Miyamoto, K. Hidaka, D. Jin, and T. Morisaki RNA-binding proteins Rbm38 and Rbm24 regulate myogenic differentiation via p21-dependent and -independent regulatory pathways Genes Cells, November 1, 2009; 14(11): 1241 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Nyman, P. Vlachos, A. Cascante, O. Hermanson, B. Zhivotovsky, and B. Joseph Protein Kinase C-Dependent Phosphorylation Regulates the Cell Cycle-Inhibitory Function of the p73 Carboxy Terminus Transactivation Domain Mol. Cell. Biol., April 1, 2009; 29(7): 1814 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Dar, A. Belkhiri, J. Ecsedy, A. Zaika, and W. El-Rifai Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells Cancer Res., November 1, 2008; 68(21): 8998 - 9004. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, E. M. Sturgis, A. K. El-Naggar, Q. Wei, and G. Li Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers Carcinogenesis, November 1, 2008; 29(11): 2120 - 2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Kim, P. I. Song, M.-H. Jeong, J.-H. An, S.-Y. Lee, S.-M. Jang, K.-H. Song, C. A. Armstrong, and K.-H. Choi TIP60 Represses Transcriptional Activity of p73{beta} via an MDM2-bridged Ternary Complex J. Biol. Chem., July 18, 2008; 283(29): 20077 - 20086. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muscolini, R. Cianfrocca, A. Sajeva, S. Mozzetti, G. Ferrandina, A. Costanzo, and L. Tuosto Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells Mol. Cancer Ther., June 1, 2008; 7(6): 1410 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sauer, A. C. Bretz, R. Beinoraviciute-Kellner, M. Beitzinger, C. Burek, A. Rosenwald, G. S. Harms, and T. Stiewe C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity Nucleic Acids Res., April 1, 2008; 36(6): 1900 - 1912. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shen, Y. Kondo, S. Ahmed, Y. Boumber, K. Konishi, Y. Guo, X. Chen, J. N. Vilaythong, and J.-P. J. Issa Drug Sensitivity Prediction by CpG Island Methylation Profile in the NCI-60 Cancer Cell Line Panel Cancer Res., December 1, 2007; 67(23): 11335 - 11343. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Malaguarnera, V Vella, R Vigneri, and F Frasca p53 family proteins in thyroid cancer Endocr. Relat. Cancer, March 1, 2007; 14(1): 43 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, L. Yao, T. Ouyang, J. Li, T. Wang, Z. Fan, T. Fan, B. Dong, B. Lin, J. Li, et al. Association of p73 G4C14-to-A4T14 (GC/AT) polymorphism with breast cancer survival Carcinogenesis, February 1, 2007; 28(2): 372 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lokshin, Y. Li, C. Gaiddon, and C. Prives p53 and p73 display common and distinct requirements for sequence specific binding to DNA Nucleic Acids Res., January 12, 2007; 35(1): 340 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dicker, A. P. Kater, C. E. Prada, T. Fukuda, J. E. Castro, G. Sun, J. Y. Wang, and T. J. Kipps CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53 Blood, November 15, 2006; 108(10): 3450 - 3457. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shu, W. Yan, and X. Chen RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript Genes & Dev., November 1, 2006; 20(21): 2961 - 2972. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Liu, K. Y.-K. Chan, A. N.-Y. Cheung, X.-Y. Liao, T.-W. Leung, and H. Y.-S. Ngan Expression of {Delta}Np73 and TAp73{alpha} Independently Associated with Radiosensitivities and Prognoses in Cervical Squamous Cell Carcinoma. Clin. Cancer Res., July 1, 2006; 12(13): 3922 - 3927. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Liu, K. Y.-K. Chan, R. C.-Y. Leung, H. K.-W. Law, T.-W. Leung, and H. Y.-S. Ngan Enhancement of the radiosensitivity of cervical cancer cells by overexpressing p73{alpha} Mol. Cancer Ther., May 1, 2006; 5(5): 1209 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Jeong, J. Bae, W.-H. Kim, S.-M. Yoo, J.-W. Kim, P. I. Song, and K.-H. Choi p19ras Interacts with and Activates p73 by Involving the MDM2 Protein J. Biol. Chem., March 31, 2006; 281(13): 8707 - 8715. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Jung, G. Liu, W. Zhou, and X. Chen Myosin VI Is a Mediator of the p53-Dependent Cell Survival Pathway. Mol. Cell. Biol., March 1, 2006; 26(6): 2175 - 2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Helton, J. Zhu, and X. Chen The Unique NH2-terminally Deleted ({Delta}N) Residues, the PXXP Motif, and the PPXY Motif Are Required for the Transcriptional Activity of the {Delta}N Variant of p63 J. Biol. Chem., February 3, 2006; 281(5): 2533 - 2542. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Racek, N. Mise, Z. Li, A. Stoll, and B. M. Putzer C-terminal p73 Isoforms Repress Transcriptional Activity of the Human Telomerase Reverse Transcriptase (hTERT) Promoter J. Biol. Chem., December 9, 2005; 280(49): 40402 - 40405. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Malaguarnera, A. Mandarino, E. Mazzon, V. Vella, P. Gangemi, C. Vancheri, P. Vigneri, A. Aloisi, R. Vigneri, and F. Frasca The p53-homologue p63 may promote thyroid cancer progression Endocr. Relat. Cancer, December 1, 2005; 12(4): 953 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jain, S. Gupta, Ch. Sudhakar, V. Radha, and G. Swarup Role of p73 in Regulating Human Caspase-1 Gene Transcription Induced by Interferon-{gamma} and Cisplatin J. Biol. Chem., November 4, 2005; 280(44): 36664 - 36673. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dulloo and K. Sabapathy Transactivation-dependent and -independent Regulation of p73 Stability J. Biol. Chem., August 5, 2005; 280(31): 28203 - 28214. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu and X. Chen The C-terminal Sterile {alpha} Motif and the Extreme C Terminus Regulate the Transcriptional Activity of the {alpha} Isoform of p73 J. Biol. Chem., May 20, 2005; 280(20): 20111 - 20119. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Toh, S. Kyo, and K. Sabapathy Relief of p53-mediated Telomerase Suppression by p73 J. Biol. Chem., April 29, 2005; 280(17): 17329 - 17338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Terrasson, S. Allart, H. Martin, J. Lule, H. Haddada, D. Caput, and C. Davrinche p73-Dependent Apoptosis through Death Receptor: Impairment by Human Cytomegalovirus Infection Cancer Res., April 1, 2005; 65(7): 2787 - 2794. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gonzalez, M. M. Perez-Perez, E. Hernando, M. Serrano, and C. Cordon-Cardo p73{beta}-Mediated Apoptosis Requires p57kip2 Induction and IEX-1 Inhibition Cancer Res., March 15, 2005; 65(6): 2186 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Li, J. Zhu, and J. Y. J. Wang Ectopic Expression of p73{alpha}, but Not p73{beta}, Suppresses Myogenic Differentiation J. Biol. Chem., January 21, 2005; 280(3): 2159 - 2164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. LOKSHIN, T. TANAKA, and C. PRIVES Transcriptional Regulation by p53 and p73 Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 121 - 128. [Abstract] [PDF] |
||||
![]() |
S. P. Cregan, N. A. Arbour, J. G. MacLaurin, S. M. Callaghan, A. Fortin, E. C. C. Cheung, D. S. Guberman, D. S. Park, and R. S. Slack p53 Activation Domain 1 Is Essential for PUMA Upregulation and p53-Mediated Neuronal Cell Death J. Neurosci., November 3, 2004; 24(44): 10003 - 10012. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Toh, M. M. Siddique, L. Boominathan, K. W. Lin, and K. Sabapathy c-Jun Regulates the Stability and Activity of the p53 Homologue, p73 J. Biol. Chem., October 22, 2004; 279(43): 44713 - 44722. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Jacobs, G. S. Walsh, and F. D. Miller Neuronal Survival and p73/p63/p53: A Family Affair Neuroscientist, October 1, 2004; 10(5): 443 - 455. [Abstract] [PDF] |
||||
![]() |
G. Li, L.-E Wang, R. M. Chamberlain, C. I. Amos, M. R. Spitz, and Q. Wei p73 G4C14-to-A4T14 Polymorphism and Risk of Lung Cancer Cancer Res., October 1, 2004; 64(19): 6863 - 6866. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, E. M. Sturgis, L.-E. Wang, R. M. Chamberlain, C. I. Amos, M. R. Spitz, A. K. El-Naggar, W. K. Hong, and Q. Wei Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck Carcinogenesis, October 1, 2004; 25(10): 1911 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Moll and N. Slade p63 and p73: Roles in Development and Tumor Formation Mol. Cancer Res., July 1, 2004; 2(7): 371 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Howell, C. Borchers, and S. L. Milgram Heterogeneous Nuclear Ribonuclear Protein U Associates with YAP and Regulates Its Co-activation of Bax Transcription J. Biol. Chem., June 18, 2004; 279(25): 26300 - 26306. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Liu, R. C.-Y. Leung, K. Y.-K. Chan, P.-M. Chiu, A. N.-Y. Cheung, K.-F. Tam, T.-Y. Ng, L.-C. Wong, and H. Y.-S. Ngan p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy Clin. Cancer Res., May 15, 2004; 10(10): 3309 - 3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Concin, K. Becker, N. Slade, S. Erster, E. Mueller-Holzner, H. Ulmer, G. Daxenbichler, A. Zeimet, R. Zeillinger, C. Marth, et al. Transdominant {Delta}TAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo Cancer Res., April 1, 2004; 64(7): 2449 - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Melino, F. Bernassola, M. Ranalli, K. Yee, W. X. Zong, M. Corazzari, R. A. Knight, D. R. Green, C. Thompson, and K. H. Vousden p73 Induces Apoptosis via PUMA Transactivation and Bax Mitochondrial Translocation J. Biol. Chem., February 27, 2004; 279(9): 8076 - 8083. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, S. Nozell, H. Xiao, and X. Chen {Delta}Np73{beta} Is Active in Transactivation and Growth Suppression Mol. Cell. Biol., January 15, 2004; 24(2): 487 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goldschneider, E. Blanc, G. Raguenez, M. Barrois, A. Legrand, G. Le Roux, H. Haddada, J. Benard, and S. Douc-Rasy Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line J. Cell Sci., January 15, 2004; 117(2): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. N. Barrera, J. A. Poveda, J. M. Gonzalez-Ros, and J. L. Neira Binding of the C-terminal Sterile {alpha} Motif (SAM) Domain of Human p73 to Lipid Membranes J. Biol. Chem., November 21, 2003; 278(47): 46878 - 46885. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gonzalez, C. Prives, and C. Cordon-Cardo p73{alpha} Regulation by Chk1 in Response to DNA Damage Mol. Cell. Biol., November 15, 2003; 23(22): 8161 - 8171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marabese, F. Vikhanskaya, C. Rainelli, T. Sakai, and M. Broggini DNA damage induces transcriptional activation of p73 by removing C-EBP{alpha} repression on E2F1 Nucleic Acids Res., November 15, 2003; 31(22): 6624 - 6632. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Puig, P. Capodieci, M. Drobnjak, D. Verbel, C. Prives, C. Cordon-Cardo, and C. J. Di Como p73 Expression in Human Normal and Tumor Tissues: Loss of p73{alpha} Expression Is Associated with Tumor Progression in Bladder Cancer Clin. Cancer Res., November 15, 2003; 9(15): 5642 - 5651. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Frasca, V. Vella, A. Aloisi, A. Mandarino, E. Mazzon, R. Vigneri, and P. Vigneri p73 Tumor-Suppressor Activity Is Impaired in Human Thyroid Cancer Cancer Res., September 15, 2003; 63(18): 5829 - 5837. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Petrenko, A. Zaika, and U. M. Moll {Delta}Np73 Facilitates Cell Immortalization and Cooperates with Oncogenic Ras in Cellular Transformation In Vivo Mol. Cell. Biol., August 15, 2003; 23(16): 5540 - 5555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Sablina, P. M. Chumakov, and B. P. Kopnin Tumor Suppressor p53 and Its Homologue p73{alpha} Affect Cell Migration J. Biol. Chem., July 18, 2003; 278(30): 27362 - 27371. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gaiddon, M. Lokshin, I. Gross, D. Levasseur, Y. Taya, J.-P. Loeffler, and C. Prives Cyclin-dependent Kinases Phosphorylate p73 at Threonine 86 in a Cell Cycle-dependent Manner and Negatively Regulate p73 J. Biol. Chem., July 18, 2003; 278(30): 27421 - 27431. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Freebern, J. L. Smith, S. S. Chaudhry, C. M. Haggerty, and K. Gardner Novel Cell-specific and Dominant Negative Anti-apoptotic Roles of p73 in Transformed Leukemia Cells J. Biol. Chem., January 17, 2003; 278(4): 2249 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Zaika, N. Slade, S. H. Erster, C. Sansome, T. W. Joseph, M. Pearl, E. Chalas, and U. M. Moll {Delta}Np73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors J. Exp. Med., September 16, 2002; 196(6): 765 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ren, R. Datta, H. Shioya, Y. Li, E. Oki, V. Biedermann, A. Bharti, and D. Kufe p73beta Is Regulated by Protein Kinase Cdelta Catalytic Fragment Generated in the Apoptotic Response to DNA Damage J. Biol. Chem., September 6, 2002; 277(37): 33758 - 33765. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Gartel and A. L. Tyner The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis Mol. Cancer Ther., June 1, 2002; 1(8): 639 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Watanabe, T. Ozaki, T. Nakagawa, K. Miyazaki, M. Takahashi, M. Hosoda, S. Hayashi, S. Todo, and A. Nakagawara Physical Interaction of p73 with c-Myc and MM1, a c-Myc-binding Protein, and Modulation of the p73 Function J. Biol. Chem., April 19, 2002; 277(17): 15113 - 15123. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakagawa, M. Takahashi, T. Ozaki, K.-i. Watanabe, S. Todo, H. Mizuguchi, T. Hayakawa, and A. Nakagawara Autoinhibitory Regulation of p73 by {Delta}Np73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the {Delta}Np73 Promoter Mol. Cell. Biol., April 15, 2002; 22(8): 2575 - 2585. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Balint, A. C. Phillips, S. Kozlov, C. L. Stewart, and K. H. Vousden Induction of p57KIP2 expression by p73beta PNAS, March 19, 2002; 99(6): 3529 - 3534. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sasaki, S. Ishida, I. Morimoto, T. Yamashita, T. Kojima, C. Kihara, T. Tanaka, K. Imai, Y. Nakamura, and T. Tokino The p53 Family Member Genes Are Involved in the Notch Signal Pathway J. Biol. Chem., January 4, 2002; 277(1): 719 - 724. [Abstract] [Full Text] |
||||
![]() |
J. Gu, L. Nie, D. Wiederschain, and Z.-M. Yuan Identification of p53 Sequence Elements That Are Required for MDM2-Mediated Nuclear Export Mol. Cell. Biol., December 15, 2001; 21(24): 8533 - 8546. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Strachan, R. Rallapalli, B. Pucci, T. P. Lafond, and D. J. Hall A Transcriptionally Inactive E2F-1 Targets the MDM Family of Proteins for Proteolytic Degradation J. Biol. Chem., November 30, 2001; 276(49): 45677 - 45685. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Hall, A C Woodman, S J Campbell, and N A Shepherd Expression of the p53 homologue p63{alpha} and {Delta}Np63{alpha} in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein Gut, November 1, 2001; 49(5): 618 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Irwin and W. G. Kaelin p53 Family Update: p73 and p63 Develop Their Own Identities Cell Growth Differ., July 1, 2001; 12(7): 337 - 349. [Full Text] [PDF] |
||||
![]() |
Y. Moriyama, S. Nishiguchi, A. Tamori, N. Koh, Y. Yano, S. Kubo, K. Hirohashi, and S. Otani Tumor-Suppressor Effect of Interferon Regulatory Factor-1 in Human Hepatocellular Carcinoma Clin. Cancer Res., May 1, 2001; 7(5): 1293 - 1298. [Abstract] [Full Text] |
||||
![]() |
C. Gaiddon, M. Lokshin, J. Ahn, T. Zhang, and C. Prives A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain Mol. Cell. Biol., March 1, 2001; 21(5): 1874 - 1887. [Abstract] [Full Text] |
||||
![]() |
F. Vikhanskaya, S. Marchini, M. Marabese, E. Galliera, and M. Broggini p73{{alpha}} Overexpression Is Associated with Resistance to Treatment with DNA-damaging Agents in a Human Ovarian Cancer Cell Line Cancer Res., February 1, 2001; 61(3): 935 - 938. [Abstract] [Full Text] |
||||
![]() |
X. Zeng, Y. Zhu, and H. Lu NBP is the p53 homolog p63 Carcinogenesis, February 1, 2001; 22(2): 215 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tan, J. Bian, K. Guan, and Y. Sun p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization Carcinogenesis, February 1, 2001; 22(2): 295 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Q. Wang, W. M. Ongkeko, A. W. S. Lau, K. M. Leung, and R. Y. C. Poon A Possible Role of p73 on the Modulation of p53 Level through MDM2 Cancer Res., February 1, 2001; 61(4): 1598 - 1603. [Abstract] [Full Text] |
||||
![]() |
J. Zhu and X. Chen MCG10, a Novel p53 Target Gene That Encodes a KH Domain RNA-Binding Protein, Is Capable of Inducing Apoptosis and Cell Cycle Arrest in G2-M Mol. Cell. Biol., August 1, 2000; 20(15): 5602 - 5618. [Abstract] [Full Text] |
||||
![]() |
M.-J. Kang, B.-J. Park, D.-S. Byun, J.-I. Park, H.-J. Kim, J.-H. Park, and S.-G. Chi Loss of Imprinting and Elevated Expression of Wild-Type p73 in Human Gastric Adenocarcinoma Clin. Cancer Res., May 1, 2000; 6(5): 1767 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Hall, S. J. Campbell, M. O'neill, D. J. Royston, K. Nylander, F. A. Carey, and N. M. Kernohan Expression of the p53 homologue p63{alpha} and {Delta}Np63{alpha} in normal and neoplasticcells Carcinogenesis, February 1, 2000; 21(2): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Levrero, V De Laurenzi, A Costanzo, J Gong, J. Wang, and G Melino The p53/p63/p73 family of transcription factors: overlapping and distinct functions J. Cell Sci., January 5, 2000; 113(10): 1661 - 1670. [Abstract] [PDF] |
||||
![]() |
S. Wienzek, J. Roth, and M. Dobbelstein E1B 55-Kilodalton Oncoproteins of Adenovirus Types 5 and 12 Inactivate and Relocalize p53, but Not p51 or p73, and Cooperate with E4orf6 Proteins To Destabilize p53 J. Virol., January 1, 2000; 74(1): 193 - 202. [Abstract] [Full Text] |
||||
![]() |
J. Roth and M. Dobbelstein Failure of viral oncoproteins to target the p53-homologue p51A J. Gen. Virol., December 1, 1999; 80(12): 3251 - 3255. [Abstract] [Full Text] |
||||
![]() |
T. Ozaki, M. Naka, N. Takada, M. Tada, S. Sakiyama, and A. Nakagawara Deletion of the COOH-Terminal Region of p73{{alpha}} Enhances Both Its Transactivation Function and DNA-binding Activity but Inhibits Induction of Apoptosis in Mammalian Cells Cancer Res., December 1, 1999; 59(23): 5902 - 5907. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fang, S. W. Lee, and S. A. Aaronson Comparative Analysis of P73 and P53 Regulation and Effector Functions J. Cell Biol., November 15, 1999; 147(4): 823 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. R. Peters, M. P. Tschan, K. A. Kreuzer, G. Baskaynak, U. Lass, A. Tobler, M. F. Fey, and C. A. Schmidt Distinct Expression Patterns of the p53-Homologue p73 in Malignant and Normal Hematopoiesis Assessed by a Novel Real-Time Reverse Transcription-Polymerase Chain Reaction Assay and Protein Analysis Cancer Res., September 1, 1999; 59(17): 4233 - 4236. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Zaika, S. Kovalev, N. D. Marchenko, and U. M. Moll Overexpression of the Wild Type p73 Gene in Breast Cancer Tissues and Cell Lines Cancer Res., July 1, 1999; 59(13): 3257 - 3263. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Corn, S. J. Kuerbitz, M. M. van Noesel, M. Esteller, N. Compitello, S. B. Baylin, and J. G. Herman Transcriptional Silencing of the p73 Gene in Acute Lymphoblastic Leukemia and Burkitt's Lymphoma Is Associated with 5' CpG Island Methylation Cancer Res., July 1, 1999; 59(14): 3352 - 3356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shimada, S. Kato, K. Enjo, M. Osada, Y. Ikawa, K. Kohno, M. Obinata, R. Kanamaru, S. Ikawa, and C. Ishioka The Transcriptional Activities of p53 and Its Homologue p51/p63: Similaritiesand Differences Cancer Res., June 1, 1999; 59(12): 2781 - 2786. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-G. Chi, S.-G. Chang, S.-J. Lee, C.-H. Lee, J. I. Kim, and J.-H. Park Elevated and Biallelic Expression of p73 Is Associated with Progression of Human Bladder Cancer Cancer Res., June 1, 1999; 59(12): 2791 - 2793. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zeng, H. Lee, Q. Zhang, and H. Lu p300 Does Not Require Its Acetylase Activity to Stimulate p73 Function J. Biol. Chem., January 5, 2001; 276(1): 48 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zaika, M. Irwin, C. Sansome, and U. M. Moll Oncogenes Induce and Activate Endogenous p73 Protein J. Biol. Chem., March 30, 2001; 276(14): 11310 - 11316. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lemasson and J. K. Nyborg Human T-cell Leukemia Virus Type I Tax Repression of p73beta Is Mediated through Competition for the C/H1 Domain of CBP J. Biol. Chem., May 4, 2001; 276(19): 15720 - 15727. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Klein, G. Georges, K.-P. Kunkele, R. Huber, R. A. Engh, and S. Hansen High Thermostability and Lack of Cooperative DNA Binding Distinguish the p63 Core Domain from the Homologous Tumor Suppressor p53 J. Biol. Chem., September 28, 2001; 276(40): 37390 - 37401. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |